Capital Fund Management (CFM)
AGIO icon

Capital Fund Management (CFM)’s Agios Pharmaceuticals AGIO Stock Holding History

Capital Fund Management (CFM)’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,300
Closed -$259K – 993
2020
Q1 		$259K Buy
+7,300
New +$337K ﹤0.01% 1293

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Capital Fund Management (CFM)'s AGIO Position: Q1 2026 in Review

Capital Fund Management (CFM) increased its Agios Pharmaceuticals (AGIO) stake by 262% in Q1 2026, buying an estimated $2.66M and bringing the position to 129,531 shares worth $4.38M. The position accounts for 0.02% of the portfolio, ranked #952.

Capital Fund Management (CFM) first reported a position in AGIO in Q2 2015 and has held it in 17 quarters since. The position peaked at $7.15M in Q3 2015. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Capital Fund Management (CFM) held 129,531 shares of Agios Pharmaceuticals worth $4.38M as of Q1 2026.
  • Capital Fund Management (CFM) bought 93,743 Agios Pharmaceuticals shares in Q1 2026, an estimated $2.66M.
  • Agios Pharmaceuticals made up 0.02% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #952 holding.
  • Capital Fund Management (CFM) first reported a position in Agios Pharmaceuticals in Q2 2015 and has held it in 17 quarters since.
  • Capital Fund Management (CFM)'s Agios Pharmaceuticals position peaked at $7.15M in Q3 2015.
  • 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.